Hepatoprotecive effects of Lycium barbarum leave's ethanol extracts in non-alcoholic fatty liver disease models and HepG2 cell

被引：0
|
作者：
Ly, Sun Yung [1 ]
Lee, Han Sol [1 ]
机构：
[1] Chungnam Natl Univ, Daejeon, South Korea
来源：
ANNALS OF NUTRITION AND METABOLISM | 2023年 / 79卷
基金：
新加坡国家研究基金会;
关键词：
Lycium barbarum's leaf; Hepatoprotecive effects; non-alcoholic fatty liver disease;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PAB(T7-249
引用
收藏
页码：1070 / 1070
页数：1
相关论文
共 50 条
  • [31] Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes
    Lakhan, Manpreet
    Denning, Michael
    Varughese, George I.
    Varadhan, Lakshminara-Yanan
    DIABETES, 2011, 60 : A684 - A684
  • [32] Finding the roadmap of a liver cell developing non-alcoholic fatty liver disease
    Pieterman, C.
    Jiang, J.
    Gerards, M.
    Ertaylan, G.
    Peeters, R.
    de Kok, T.
    TOXICOLOGY LETTERS, 2022, 368 : S194 - S194
  • [33] Docosahexaenoic Acid (DHA), not Leucine, May Protect HepG2 Cells from Palmitate-Induced Non-Alcoholic Fatty Liver Disease
    Baum, Jamie I.
    Carroll, Timothy G.
    Shouse, Stephanie A.
    FASEB JOURNAL, 2017, 31
  • [34] Hepatoprotective effects of Cassia semen ethanol extract on non-alcoholic fatty liver disease in experimental rat
    Meng, Yuanyuan
    Liu, Yong
    Fang, Ningning
    Guo, Yongmin
    PHARMACEUTICAL BIOLOGY, 2019, 57 (01) : 98 - 104
  • [35] Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease
    Carranza-Trejo, Azalia Mariel
    Vetvicka, Vaclav
    Vistejnova, Lucie
    Kralickova, Milena
    Montufar, Edgar B.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (07) : 783 - 796
  • [36] Mast Cell Involvement in Non-Alcoholic Fatty Liver Disease in Humans
    Dela Cruz, Anna Christina
    Altintas, Mehmet M.
    De La Cruz-Munoz, Nestor
    Gaidosh, Gabriel S.
    Arosemena, Leopoldo
    Nadji, Mehrdad
    Garcia-Buitrago, Monica
    Nayer, Ali
    HEPATOLOGY, 2015, 62 : 660A - 660A
  • [37] Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease
    Lemmer, Peter
    Manka, Paul
    Best, Jan
    Kahraman, Alisan
    Kaelsch, Julia
    Vilchez-Vargas, Ramiro
    Link, Alexander
    Chiang, Hsin
    Gerken, Guido
    Canbay, Ali
    Bechmann, Lars P.
    Sydor, Svenja
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (03)
  • [38] Cardiometabolic effects of antidiabetic drugs in non-alcoholic fatty liver disease
    Rix, Iben
    Pedersen, Julie Steen
    Storgaard, Heidi
    Gluud, Lise Lotte
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2019, 39 (02) : 122 - 127
  • [39] Non-alcoholic fatty liver disease and beneficial effects of dietary supplements
    Abenavoli, Ludovico
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (12) : 1723 - 1724
  • [40] Beneficial Effects of Dietary Flaxseed on Non-Alcoholic Fatty Liver Disease
    Parikh, Mihir
    Hirst, Broderick C.
    O'Hara, Kimberley A.
    Maddaford, Thane G.
    Austria, J. Alejandro
    Stamenkovic, Aleksandra
    Yu, Liping
    Kura, Branislav
    Garg, Bhavana
    Netticadan, Thomas
    Proctor, Spencer D.
    Pierce, Grant N.
    NUTRIENTS, 2024, 16 (04)
12345